Neubauer Aljoscha S, Ulbig Michael W
Department of Ophthalmology, Ludwig Maximilians University Munich, Munich, Germany.
Ophthalmologica. 2007;221(2):95-102. doi: 10.1159/000098254.
Diabetic retinopathy is a leading cause of visual impairment and blindness in developed countries due to macular edema and proliferative diabetic retinopathy (PDR). For both complications laser treatment may offer proven therapy: the Diabetic Retinopathy Study demonstrated that panretinal scatter photocoagulation reduces the risk of severe visual loss by >50% in eyes with high-risk characteristics. Panretinal scatter coagulation may also be beneficial in other PDR and severe nonproliferative diabetic retinopathy (NPDR) under certain conditions. For clinically significant macular edema the Early Treatment of Diabetic Retinopathy Study could show that immediate focal laser photocoagulation reduces the risk of moderate visual loss by at least 50%. When and how to perform laser treatment is described in detail, offering a proven treatment for many problems associated with diabetic retinopathy based on a high evidence level.
在发达国家,糖尿病性视网膜病变是导致视力损害和失明的主要原因,这是由黄斑水肿和增殖性糖尿病性视网膜病变(PDR)引起的。对于这两种并发症,激光治疗可能是经过验证的疗法:糖尿病性视网膜病变研究表明,对于具有高危特征的眼睛,全视网膜光凝可将严重视力丧失的风险降低50%以上。在某些情况下,全视网膜光凝对其他PDR和严重非增殖性糖尿病性视网膜病变(NPDR)也可能有益。对于临床上显著的黄斑水肿,糖尿病性视网膜病变早期治疗研究表明,立即进行局部激光光凝可将中度视力丧失的风险至少降低50%。文中详细描述了何时以及如何进行激光治疗,基于高证据水平为许多与糖尿病性视网膜病变相关的问题提供了经过验证的治疗方法。